Evidence map›Paper›PMID 22514597›Full record

ArticlePloS one2012

Identification of spectral modifications occurring during reprogramming of somatic cells.

Christophe Sandt, Olivier Féraud, Noufissa Oudrhiri, Marie Laure Bonnet, Marie Claude Meunier, Yannick Valogne, Angelina Bertrand, Martine Raphaël, Frank Griscelli, Ali G Turhan and 2 more

Abstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Discrimination and Prediction ofMolecules (Basel, Switzerland) · 2022
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Christophe SandtSOLEIL Synchrotron, Saint Aubin, Gif sur Yvette, France.
Olivier Féraud
Noufissa Oudrhiri
Marie Laure Bonnet
Marie Claude Meunier
Yannick Valogne
Angelina Bertrand
Martine Raphaël
Frank Griscelli
Ali G Turhan
Paul Dumas
Annelise Bennaceur-Griscelli

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent technological advances in cell reprogramming by generation of induced pluripotent stem cells (iPSC) offer major perspectives in disease modelling and future hopes for providing novel stem cells sources in regenerative medicine. However, research on iPSC still requires refining the criteria of the pluripotency stage of these cells and exploration of their equivalent functionality to human embryonic stem cells (ESC). We report here on the use of infrared microspectroscopy to follow the spectral modification of somatic cells during the reprogramming process. We show that induced pluripotent stem cells (iPSC) adopt a chemical composition leading to a spectral signature indistinguishable from that of embryonic stem cells (ESC) and entirely different from that of the original somatic cells. Similarly, this technique allows a distinction to be made between partially and fully reprogrammed cells. We conclude that infrared microspectroscopy signature is a novel methodology to evaluate induced pluripotency and can be added to the tests currently used for this purpose.

Indexed as

AnimalsCellular ReprogrammingEmbryonic Stem CellsHumansInduced Pluripotent Stem CellsMiceSpectroscopy, Fourier Transform Infrared

Identifiers

PMID22514597
PMCPMC3326006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.